Tests to Check for Kidney Damage
The two essential tests to check for kidney damage are: (1) serum creatinine to calculate estimated glomerular filtration rate (eGFR), and (2) urine albumin-to-creatinine ratio (UACR) to detect proteinuria. 1
Core Screening Tests
Blood Tests
- Serum creatinine with eGFR calculation is the primary test to assess kidney function, with eGFR <60 mL/min/1.73 m² indicating chronic kidney disease regardless of other findings 1
- Use the CKD-EPI equation (preferred) or MDRD equation to estimate GFR from serum creatinine, age, sex, and race—never rely on serum creatinine alone as it grossly overestimates kidney function 1
- Cystatin C can be used as an alternative marker when creatinine-based estimates are unreliable (extremes of muscle mass, dietary variations) 2
Urine Tests
- Spot urine albumin-to-creatinine ratio (UACR) is the preferred method to detect kidney damage, with values ≥30 mg/g indicating abnormal albumin excretion 1
- Urinalysis screens for proteinuria (≥1+ on dipstick roughly correlates to ≥30 mg/dL), hematuria, and active sediment that may indicate glomerular disease 1
- First morning void is preferred for UACR to minimize variability, though random samples are acceptable in adults 3
Screening Frequency and Target Populations
Who Should Be Screened
- All patients with diabetes or hypertension should have annual eGFR and UACR testing 1
- High-risk populations requiring annual screening include: African Americans, patients with hepatitis C, those with HIV RNA >4,000 copies/mL or CD4+ <200 cells/mL, patients with cardiovascular disease, obesity, or family history of kidney disease 1
- Patients over age 50 should be considered for screening given age-related decline in kidney function 1, 4
Testing Schedule
- Perform annual screening for at-risk populations with normal baseline results 1
- Increase to every 6 months when eGFR is 45-60 mL/min/1.73 m² 1
- Test every 3 months when eGFR is 30-44 mL/min/1.73 m² 1
Staging Kidney Disease
Chronic kidney disease is defined as either kidney damage or eGFR <60 mL/min/1.73 m² persisting for ≥3 months 1:
- Stage 1: eGFR ≥90 with evidence of kidney damage (proteinuria, imaging abnormalities) 1
- Stage 2: eGFR 60-89 with evidence of kidney damage 1
- Stage 3: eGFR 30-59 (kidney disease present regardless of other markers) 1
- Stage 4: eGFR 15-29 (severe kidney dysfunction) 1
- Stage 5: eGFR <15 or on dialysis (kidney failure) 1
Additional Diagnostic Tests When Kidney Disease Is Confirmed
Laboratory Evaluation
- Electrolytes and potassium should be checked at least yearly in all CKD patients 1
- Complete metabolic panel including bicarbonate, calcium, phosphorus when eGFR <60 1
- Hemoglobin to screen for anemia of CKD 1
- Parathyroid hormone when eGFR <60 to detect mineral bone disorder 1
- Hepatitis B and C serology, complement levels, antinuclear antibody, cryoglobulin, immunoglobulin levels, serum and urine protein electrophoresis to identify underlying causes of CKD 1
Imaging Studies
- Renal ultrasound provides information on kidney size, stones, masses, and structural abnormalities 1
- Small kidneys (<9 cm length) suggest advanced irreversible disease, while large echogenic kidneys may indicate certain diagnoses but are not diagnostic alone 1
Critical Pitfalls to Avoid
- Never use serum creatinine alone without calculating eGFR—a "normal" creatinine of 1.3 mg/dL can mask significant kidney dysfunction 1
- Do not rely on 24-hour creatinine clearance for routine screening—it is less accurate than eGFR equations and prone to collection errors 1
- Confirm proteinuria with quantitative testing (UACR or protein-to-creatinine ratio) if dipstick is positive, as transient proteinuria from exercise, fever, or UTI is common 1, 3
- Avoid testing during menstruation or within 24 hours of vigorous exercise, as both cause false-positive proteinuria 3
When to Refer to Nephrology
Referral is indicated when 1:
- eGFR <30 mL/min/1.73 m² (Stage 4 CKD)
- Rapid decline in eGFR (>25% decrease)
- Severe proteinuria (UACR >300 mg/g or protein-to-creatinine ratio >1,000 mg/g)
- Active urinary sediment with dysmorphic red blood cells or red cell casts
- Uncertain etiology of kidney disease
- Resistant hypertension or difficult-to-manage complications (anemia, hyperparathyroidism, electrolyte disturbances)